BERGEN WOULD COMPETE WITH BRISTOL IN ONCOLOGY MARKET AFTER IVAX MERGER: FIRMS ALREADY COMPETE IN ONCOLOGY DISTRIBUTION; IVAX EXPANDS GLAXO INHALER DEAL
Executive Summary
Bergen Brunswig is edging toward direct competition with Bristol-Myers Squibb in the oncology therapeutics field as a result of the wholesaler's proposed acquisition of Ivax.